Iron Sucrose/Tin Protoporphyrin

蔗糖铁/锡原卟啉

Report date: 2025/07/04 09:44:11

Base Information

Drug NameIron Sucrose/Tin Protoporphyrin
Drug Alias NameFeS/SnPPRBT-1
ClassificationSmall molecules
Mechanisms of ActionIron Supplements
TargetsNot applicable
Therapy Area/IndicationsPostoperative ComplicationsHeart DiseasesRenal Insufficiency, Chronic +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia
CombinationsYes Iron sucrose
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRenibus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRenibus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPostoperative ComplicationsHeart DiseasesAcute Kidney Injury
Inactive IndicationsRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A